Intimation of rejection of application for reclassification of shareholder from Promoter Group to Public Category under regulation 31A of SEBI (Listing Regulations and Disclosure Requirements) Regulation,2015.

pdf

Link Pharma Chem Ltd.

08 Feb 2025

33.15

1.50%

Company Update

LINK PHARMA CHEM LTD. - 524748 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Advertisements of Unaudited Financial Results for the quarter and nine months ended December 31, 2024.

pdf

Link Pharma Chem Ltd.

07 Feb 2025

33.15

1.50%

Corp. Note

LINK PHARMA CHEM LTD. - 524748 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024.

pdf

Link Pharma Chem Ltd.

07 Feb 2025

33.15

1.50%

Board Meeting

LINK PHARMA CHEM LTD. - 524748 - Board Meeting Outcome for Board Meeting Outcome For Outcome …

BSE India

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board has at its meeting held on today i.e. 7th February, 2025 approved the Unaudited Financial Results of the Company for the quarter and nine months period ended December 31, 2024 along with the Limited Review Report of the Statutory Auditors. Please find enclosed herewith Limited Review Report and Unaudited Financial Results for the quarter and nine months period ended December 31, 2024.

pdf

Link Pharma Chem Ltd.

07 Feb 2025

33.15

1.50%

Result

LINK PHARMA CHEM LTD. - 524748 - Unaudited Financial Results For The Quarter And Nine Months …

BSE India

Unaudited Financial Results for the quarter and half year ended on December 31, 2024.

pdf

Link Pharma Chem Ltd.

28 Jan 2025

33.15

1.50%

Board Meeting

LINK PHARMA CHEM LTD. - 524748 - Board Meeting Intimation for Considering And Approval Of Unaudited …

BSE India

LINK PHARMA CHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 ,inter alia, to consider and approve The unaudited financial results of the Company for the quarter and nine months ended on December 31, 2024.

pdf